BriaCell: An Emerging Immuno-Oncology Company
August 14, 2023 at 12:24 PM EDT
BriaCell has recently announced agreement with the FDA for their pivotal, registration trial in advanced metastatic breast cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.